Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...
HOLLISTON, Mass., Feb. 17, 2026 /PRNewswire/ -- Esco Tool has introduced a full line of standard and custom cutter blades that are precision ground in-house for producing high quality weld preps on ...
DERBY, DERBYSHIRE, UNITED KINGDOM, March 9, 2026 /EINPresswire.com/ -- LOBO Systems has successfully deployed its ...
Patient reported outcomes with Orca-T ® from the pivotal Precision-T Phase 3 study will be presented including quality of life and rates of rehospitalizations compared to conventional alloHSCT Data ...
Orca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT Patient reported outcomes with Orca-T® from the pivotal Precision-T Phase 3 ...
(NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today ...
Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...
8h
GNQ Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)
GNQ Insilico Inc. (“GNQ” or the “Company”), a corporation formed under the federal laws of Canada, and IB Acquisition Corp. (Nasdaq: IBAC) (“IBAC”), a Nevada special purpose acquisition company, today ...
Chinese Top 3 Leading Stainless Steel Color Pipe Manufacturers - Shaping the Future of Steel Products CALIFORNIA, CA, ...
Praxis Precision Medicines develops therapies for central nervous system disorders, targeting unmet needs in neurology and psychiatry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results